PAF may be involved in the pathogenesis of this hyperplastic inflammatory skin disease (7).
Keratinocytes are the predominant cell type in the epidermis and are capable of responding to, and synthesizing a variety of pro-proliferative and pro-inflammatory cytokines (interleukin-1, interleukin-6, transforming growth factor-a, tumor necrosis factor and granulocyte/monocyte colony stimulating factor) and eicosanoids (PGE,, PGF, and 12-HETE) (8-13). Treatment of keratinocytes in vitro and skin in vivo with the PK-C activator 12-O-tetradecanoylphorbol-13-acetate (TPA) induces many of these mediators (lo-12) , suggesting that their levels may be regulated in some manner by PK-C. This concept is further supported by the demonstration that the psoriasis-like inflammatory reaction of mouse skin to TPA is blocked by the PK-C inhibitor sphingosine (14) . The ability of PAP to induce cutaneous inflammation thus raises the possibility that it may act to induce the release pro-inflammatory mediators from epidermal keratinocytes via direct activation of the PLC/PK-C signal transduction system. Alternatively, PAF may directly activate mediator release from fibroblasts within the dermis which then in turn may act on keratinocytes. To investigate this issue we have examined the ability of PAF to induce phosphoinositide turnover and arachidonic acid mobilization in cultured adult human keratinocytes and dermal fibroblasts.
MATERIALS AND METHODS

Materials.
[Y-~'P]ATP, [SH]arachidonic acid, [sH]myo-inositol and prostaglandin Es radioimmunoassay assay kit were obtained from New England Nuclear (Boston, MA). Pertussls toxin was purchased from List Biochemicals (Campbell, CA). Platelet activating factor was obtained from Serdary Biochemicals, (London, Canada). Lyso-platelet activating factor, phosphatidylcholine, phosphatidylserine and lyso-phosphatidylcholine were from Avanti Polar Lipids (Birmingham, AL). Dowex 1X-8 formate form was from BioRad Laboratories (Richmond, CA). Modified MCDB 153 keratinocyte growth media (KGM) and growth factor free keratinocyte basal media (KBM) were obtained from Clonetics, Inc. (San Diego, CA).
Cell Culture, Keratome biopsies (0.2 mm depth) of human epidermis were obtained from adult volunteers. Epidermal cells were disaggregated by incubation at 37" for 30 minutes in 0.25% trypsin, 0.1% EDTA. Cells were plated at lo7 cells/T-75 flask in KGM (15). Cells were expanded by passage at 80% confluency and utilized between passage 2 and 6. Dermal fibroblasts were grown from dermal explants in McCoy's 5A media containing 10% fetal calf serum.
La ellin b f I'Hlinositol ohosohates, Keratinocytes and fibroblasts were seeded in 35mm dishes and allowed to grow to 70% confluency. Keratinocytes were labelled with [SH]myo-inositol (l@i/ml) in inositol free KBM for 48 hours. Fibroblasts were labelled similarly in Medium 199. The media was removed and cells were incubated in phosphate buffered saline containing 1OmM LiCl for 10 minutes prior to addition of agonist. Following stimulation, ice cold methanol/HCL (21:0.01) was added and the cells scraped from the dish.
[3HJinositol phosphates were separated by Dowex ion exchange chromatography and quantified by liquid scintillation counting (16).
Measurement of 1.2-diacvlnlvcerol, Cellular 1,2-diacylglycerol content was determined by the method of Preiss et al., utilizing E. Coli diacylglycerol kinase (17) .
. . . FO% cozfluentf inr 3~~m?lishes) wire labelledrwithlIsHl~ra&donic acid (0.5 rr(=i/ml) for 16 ( Keratinocytes and fibroblasts hours in KBM and Delbecco's modified Eagles medium w&h 0.2% fetal calf serum, respectively. The cells were washed to remove unincorporated radioactivity and placed in 1 ml of media. At the indicated times following addition of agonist, 0.5 ml of media was removed, acidified and extracted with an equal volume of ethylacetate. The ethylacetate extracts were dried in scintillation vials and counted. For measurement of prostaglandin Es, keratinocytes were grown in KGM con-taining 1pM unlabelled arachidonic acid for 24 hours. Cells were washed with KBM to remove unincorporated arachidonic acid prior to stimulation with agonist for the indicated times. Prostaglandin Es in the media was determined using a commercial radioimmunoassay kit.
RESULTS AND DISCUSSION:
Exposure of cultured adult human keratinocytes to PAF (1pM) resulted in rapid significant elevations in IPs, IPs and IP (figure 1). IP, was maximally elevated @-fold) within 15 seconds and remained above the initial level for at least 4 minutes, IP, increased over 1 minute and remained maximally elevated (&fold) for at least 4 minutes. IP increased steadily between 0 and 4 minutes to a level IO-fold above the initial value. Increased formation of inositol phosphates was detected at PAF concentrations between 10~'"-10~6 M (data not shown). Half maximal stimulation ocurred at 5 X lo-'M PAF.
The effect of several different phospholipids on accumulation of inositol phosphates was examined. Phosphatidylcholine, lyso-phosphatidylcholine and phosphatidylserine at iO'6M and lyso-PAF at IO-'M were unable to simulate formation of inositol phosphates in human keratinocytes (data not shown). These data indicate that the ability of PAF to induce formation of inositol phosphates is specific.
In a variety of cell types, agonist-induced phosphoinositide hydrolysis is inhibited by TPA and in some cases by pertussis toxin. Evidence indicates that these agents act to uncouple agonist receptors from phospholipase C by inhibition of an as yet unidentified GTP-binding Finure 3, Time course of PAF-induced formation of 1,2-diacylglycerol (DAG) in cultured human keratinccytes. Keratinocytes (4.5X106/100mm dish) were treated with PAF (1pM) for the indicated times. At the termination of the incubation, media was aspirated and the cells were scraped from the dish in ice cold methanol. DAG was extracted and quantified as described in "METHODS". Data points are the means of triplicate dishes from a representative experiment.
The experiment was repeated three times with similar results. sistent with PAF acting through specific receptors expressed on human keratinocytes coupled via a G-protein to phospholipase C.
In addition to producing IP,, agonist-induced phosphoinositide turnover is associated with the production of a second intracellular messenger DAG. We therefore investigated the effects of PAF on DAG content in cultured keratinocytes. Addition of PAF caused a rapid transient increase in DAG content (figure 3). DAG was maximally stimulated (2-fold) within 1 minute and remained elevated for 5 minutes, after which it returned to the initial level. The slower kinetics of PAF-induced DAG formation compared to that of IP, (figure 1) suggest that phospholipid headgroup classes other than phosphoinositides may serve as sources for at least some portion of the elevated DAG, as has been observed in PAF-stimulated peritoneal macrophages (22).
In addition to stimulating phosphoinositide turnover and DAG formation in human keratinocytes, PAF also elicited mobilization of arachidonic acid and prostaglandin Es synthesis. PAF-stimulated release of radioactivity from keratinocytes labelled with ['Hlarachidonic acid was dose and time dependent. Arachidonic acid release was elevated within 5 minutes and continued to increase over 30 minutes ( figure 4A ).
Release of radioactivity from [zH]arachidonic acid labelled keratinocytes was elevated 3-fold and prostaglandin Es release was elevated S-fold following exposure of keratinocytes to PAF for 15 minutes ( figure 4B) . A recent report indicates that human dermal fibroblasts are capable of synthesizing PAF (23). Since cells that synthesize PAF often also respond to it, dermal fibroblasts, in addition to keratinocytes, may be targets for the actions of PAF in skin. To investigate this, we determined whether PAF was able to stimulate phosphoinositide turnover and/or arachidonic acid mobi- phospholipase C agonist in fibroblasts (24) significantly elevated inositol phosphates and release of arachidonic acid (Table I ). The lack of responsiveness of cultured human dermal fibroblasts to PAF suggests that these cells may not express PAF receptors.
The above data demonstrate that adult human keratinocytes, but not dermal fibroblasts, are direct targets for the actions of PAF. PAF activates both arms of the bifurcating PLC/PK-C signal transduction system in human keratinocytes, stimulating IP, and DAG formation. In addition, PAF induces eicosanoid release. The activation of keratinocytes by PAF is likely to be an important mechanism through which PAF exerts its inflammatory effects in skin. Infiltration of polymorphonuclear leukocytes and macrophages, which synthesize PAF, is commonly observed in We have previously demonstrated that inflammatory factors such as bradykinin, thrombin and histamine also stimulate phospholipase C-catalyzed phosphoinositide turnover and elevate DAG content in human keratinocytes (25) . We therefore propose that the phospholipase C/protein kinase C signal transduction system in human keratinocytes is a key pathway through which mediators of skin inflammation act. This hypothesis predicts that receptor antagonists of PAF, bradykinin, histamine, and thrombin and inhibitors of phospholipase C and protein kinase C might be effective anti-inflammatory agents in skin. Investigations are in progress to address this issue.
